# Sclerosing Angiomatoid Nodular Transformation of the Spleen: A Case Report Highlighting Diagnostic Challenges and the Role of Immunohistochemistry

**Authors:** Thanh Thao Nguyen, Mitsuaki Yoshida, Vu Dung, Motona Kumagai, Sohsuke Yamada

PMC · DOI: 10.7759/cureus.89994 · 2025-08-13

## TL;DR

This case report describes a rare benign spleen condition called SANT and highlights the importance of immunohistochemistry in accurate diagnosis.

## Contribution

The paper presents a new case of SANT and emphasizes the role of immunohistochemistry in distinguishing it from other vascular tumors.

## Key findings

- SANT was diagnosed through histopathology and immunohistochemistry showing tri-phenotypic vascular profiles.
- The case ruled out associations with EBV and IgG4-related diseases.
- SANT should be considered in the differential diagnosis of splenic masses in young patients.

## Abstract

Sclerosing angiomatoid nodular transformation (SANT) of the spleen is a rare, benign vascular lesion that poses significant diagnostic challenges owing to its nonspecific clinical and radiological features. We herein report the case of a 35-year-old male who presented with chronic left hypochondrial pain and was found to have a splenic mass with poor enhancement on computed tomography (CT) and an increased fluorodeoxyglucose uptake on positron emission tomography-CT. Total splenectomy was performed, and a histopathological examination revealed well-demarcated angiomatoid nodules with varying vascular channels, fibrosclerosis, and hemosiderin deposition. Immunohistochemistry revealed a characteristic tri-phenotypic vascular profile of CD34+/CD31+/CD8− capillaries, CD8+/CD31+/CD34− sinusoid-like vessels, and CD31+ venules. Additional investigations ruled out associations between Epstein-Barr virus (EBV) and IgG4-related diseases. This case underscores the critical role of histopathology and immunohistochemistry in accurately diagnosing SANT and differentiating it from other splenic vascular tumors. We also emphasize the importance of considering SANT in the differential diagnosis of splenic masses, even in younger patients presenting with persistent unexplained abdominal pain.

## Linked entities

- **Proteins:** CD34 (CD34 molecule), PECAM1 (platelet and endothelial cell adhesion molecule 1), CD8A (CD8 subunit alpha)

## Full-text entities

- **Genes:** CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CD34 (CD34 molecule) [NCBI Gene 947], PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}
- **Diseases:** vascular lesion (MESH:D014652), splenic vascular tumors (MESH:D013160), splenic mass (MESH:D013158), SANT (MESH:D012598), hypochondrial pain (MESH:D010146), fibrosclerosis (MESH:C537375), IgG4-related diseases (MESH:D000077733), abdominal pain (MESH:D015746)
- **Chemicals:** fluorodeoxyglucose (MESH:D019788)
- **Species:** human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12350054/full.md

---
Source: https://tomesphere.com/paper/PMC12350054